Considering that both CDK7 and CDK9 play essential roles in regulation of transcription, therefore we speculated that dual targeting CDK7 and CDK9 may be a promising strategy to treat ESCC. The gene discussed is CDK7; the disease is esophageal squamous cell carcinoma.